HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Daping Hospital， Third Military Medical University, Chongqing, Chongqing Municipality

Phase

Safety & dosing

Sponsor

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Collaborators

Southwest Hospital, China, Xinqiao Hospital of Chongqing

Enrollment target

~100 participants

Started

October 2024

Primary completion

September 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated November 2024